PALB2 and ovarian cancer: In our analysis recurrent PALB2 mutations were detected in 12 out of 2095 (0.57%) unselected ovarian cancer cases giving the odds ratio of 3.34, but the difference was of borderline statistical significance (95% CI: 1.06–14.6; p = 0.06).